Cargando…
RASAL2 regulates the cell cycle and cyclin D1 expression through PI3K/AKT signalling in prostate tumorigenesis
Prostate cancer (PCa) growth and progression are uniquely dependent on androgens, making the androgen receptor pathway a prime target for therapy; however, cancer progression to androgen independence leads to treatment failure and poor prognosis. In recent years, alternative therapeutic pathways for...
Autores principales: | Wang, Qi, Wu, Shiqi, Gu, Yanan, Liang, Hua, He, Fei, Wang, Xinyang, He, Dalin, Wu, Kaijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170709/ https://www.ncbi.nlm.nih.gov/pubmed/35668070 http://dx.doi.org/10.1038/s41420-022-01069-3 |
Ejemplares similares
-
The expression and function of RASAL2 in renal cell carcinoma angiogenesis
por: Hui, Ke, et al.
Publicado: (2018) -
RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
por: Hui, Ke, et al.
Publicado: (2017) -
MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma
por: Yue, Yangyang, et al.
Publicado: (2020) -
The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression
por: Wang, Bin, et al.
Publicado: (2020) -
RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcinoma
por: Yue, Yangyang, et al.
Publicado: (2022)